Originally Posted by
mod1-4
now this isnt my opinion just asking others and if they feel any truth to it
TURINABOL should be used in all of your cycles as a BASE.
TURINABOL INSTEAD OF TEST--Using Testosterone as a base is NOT NECCESSARY. For those concerned with potential side effects(Gyno, Acne, MPB) and overall effect on the endrocrine system and the HPTA, Turinabol may be used in place of traditional testosterone based stacks.
It is a pure ANABOLIC--exhibiting almost zero androgenic activity and having NO metabolites. (as opposed to TEST, which has many metabolites, two of which are ESTROGEN and DHT--do we really want that with a BASE?)
It STIMULATES LIBIDO BIG TIME! Free Testosterone levels have been clinically demonstrated to increase by 4.5 times with one single 40mg dose. Furthermore, it has a very minimal impact on HPTA function in comparison to more traditional bulking/base compounds, AND due to its INCREDIBLE affinity to bind with SHBG and increase FREE testosterone levels, "a REBOUND of testosterone occured within 5 days of cessation" on Turinabol. Not only was recovery SWIFT, but one may CONTINUE making gains throughout post cycle therapy.
It stimulates APPETITE. Need I say more?
DOES NOT AROMATIZE OR CONVERT to DHT at ANY DOSAGE. Due to its alklyzation at the 17th position, it has an inability to convert to estrogen. This is precisely what what we want from a BASE compound. This is also another reason why recovery is so easy, as there is no circulating excess estrogen to trigger a negative feedback.
Can be STACKED with ANY COMPOUND. It is purely anabolic, so depending on ones goals, we may stack it with any compound. For a BULKING cycle with MINIMAL sides, I would reccomend a low TBOL/EQ, TBOL/NPP, TBOL/Primo, TBOL/TREN, and if one were not concerned with estrogen related sides, I would use TBOL/DBOL, or TBOL/TEST E,P,C. For CUTTING cycles, one may use TBOL/VAR, TBOL/PRIMO, TBOL/WINNY.
[The pharmacokinetics of Oral-Turinabol in humans]
[Article in German]
Schumann W.
Institut fur Mikrobiologie und experimentelle Therapie (ZIMET), Jena.
Disposition and excretion of the anabolic steroid Oral-Turinabol (1;4-chloro-17 alpha-methyl-androsta-1,4-diene-17 beta-hydroxy-3-one) were investigated in male volunteers. Following single p.o. and i.v. administration of the tritium-labelled compound the plasma concentration courses of total radioactivity (1 and 1-metabolites) and of the unchanged parent drug as well as the urinary excretion were estimated. From these data model independent pharmacokinetic parameters based on statistical moments were calculated. 1 is almost completely absorbed after p.o. administration of 10 mg per volunteer. Peak concentrations of total radioactivity and of 1 in plasma were reached about 3 h p.a. Irregularities observed in the plasma level profile following both p.o. and i.v. administration of 1 are due to a marked enterohepatic circulation. Orally given 1 is subject to a first-pass effect, resulting in a diminished systematic availability. The AUC-ratio of the unchanged drug and the total radioactivity of 1 : 13 shows the predominance of metabolites in plasma. After i.v. administration the disposition of unchanged 1 was found biphasically with a terminal half-life of 16 h. 1 and its metabolites are preferentially excreted via the kidneys. The urinary total radioactivity represented about 60% of the dose following both administrations. Due to its affinity to SHBG 1 is able to compete for the protein binding of testosterone, resulting in an increased plasma level of non protein-bound testosterone.
Reply With Quote
